Epsilico

Epsilico is at the forefront of biotechnology research, dedicated to generating innovative drugs for the most challenging targets. Leveraging cutting-edge generative AI technology, Epsilico is committed to developing effective and safe biologics for diseases with significant unmet needs. The primary address for Epsilico is located in Berlin, 1011, DE.

Epsilico's approach combines advanced computational methods with deep biological insight to accelerate the discovery and development of novel therapeutics. The company is focused on creating solutions that can transform patient outcomes and improve the quality of life for individuals affected by serious illnesses.

With a forward-looking vision, Epsilico is driven by a passion for scientific excellence and a commitment to making a meaningful impact on global health. We invite the management team at Epsilico to create a customized and exclusive company showcase and product listing on our platform to further highlight their groundbreaking work.